Status:

COMPLETED

A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee

Lead Sponsor:

Kyunghee University Medical Center

Collaborating Sponsors:

Kyung Hee University Hospital at Gangdong

Hamsoa Pharmaceutical Co., Ltd.

Conditions:

Osteoarthritis, Knee

Eligibility:

All Genders

35-80 years

Phase:

PHASE2

Brief Summary

This trial is a multi-center, randomized, double-blind, placebo-controlled, parallel, phase II clinical trial and aimed at osteoarthritis of the knee. Patients who signed informed consent voluntarily...

Eligibility Criteria

Inclusion

  • Being between 35 and 80 years of age
  • Diagnosed with Osteoarthritis of the knee at least 3 months
  • Diagnosed with Osteoarthritis of the knee, based on ACR criteria
  • Able to communicate with researchers and write questionnaires
  • At the screening visit, checking 100mm Pain VAS at least 80mm
  • At randomization(Visit 2), checking 100mm Pain VAS over 50mm
  • Agreeing to participate and signing informed consent voluntarily

Exclusion

  • Previous intra-articular injection on knee within 3 months
  • Previous knee surgery within 6 months or scheduled procedures
  • Other diseases that could affect or interfere with the therapeutic outcomes
  • Experiencing habitual use of psychotropic, narcotic analgesic drugs over 1 week
  • Diagnosed with gastrointestinal diseases, unable to stop medicines during the study
  • At the screening visit, identified liver dysfunction
  • At the screening visit, identified renal dysfunction
  • Patients who cannot take NSAIDs
  • Pregnancy and breast-feeding (women of childbearing age need pregnancy test)
  • Physicological or mental disorders, including drug-takers
  • Orthopedic diseases that could affect or interfere with the therapeutic outcomes
  • Inappropriate for the study

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2014

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT01873053

Start Date

April 1 2013

End Date

August 1 2014

Last Update

November 24 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kyung Hee University Oriental Medicine Hospital at Gangdong

Seoul, South Korea, 134-727

A 12 Week, Phase II Trial to Evaluate the Efficacy and Safety of WIN-34B in Patients With Osteoarthritis of the Knee | DecenTrialz